Angiotensin blockade for diabetes: Monitor microalbuminuria?

MOspace/Manakin Repository

Breadcrumbs Navigation

Angiotensin blockade for diabetes: Monitor microalbuminuria?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/3594

[+] show full item record


Title: Angiotensin blockade for diabetes: Monitor microalbuminuria?
Author: Muench, John; Blenning, Carol E.; Judkins, Dolores Zegar
Keywords: angiotensin-converting enzyme (ACE) inhibitor
disease progression
patient monitoring
diabetes mellitus
Date: 2007-02
Publisher: Family Physicians Inquiries Network
Citation: Journal of Family Practice, 56(2) 2007: 145-146.
Abstract: No studies address whether continued screening for microalbuminuria once a patient is taking an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-2 receptor blocker (ARB) improves outcomes. Indirect evidence and expert opinion suggest that it may be beneficial to continue microalbuminuria surveillance to assess response to therapy and monitor disease progression (strength of recommendation: C, based on expert opinion).
URI: http://hdl.handle.net/10355/3594

Items in MOspace are protected by copyright, with all rights reserved, unless otherwise indicated.

This item appears in the following Collection(s)

[+] show full item record